Iambic Therapeutics Announces IPO Of Common Stock; Applies To List Common Stock On NASDAQ Global Select Market Under Symbol 'IAM'; NVIDIA Corporation Beneficially Owned 9.6M Shares Of Iambic Therapeutics Prior To Offering

Iambic Therapeutics has announced an initial public offering (IPO) of its common stock and is applying to list on the NASDAQ Global Select Market under the ticker symbol 'IAM'. Prior to the offering, NVIDIA Corporation beneficially owned 9.6 million shares of Iambic Therapeutics.